Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113
about
Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.Phase II study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed and cisplatin for locally advanced oesophageal squamous cell carcinoma.A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer.Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinomaEvaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis.Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma.Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinomaFactors Influencing Compliance to Radical Treatment of Middle Thoracic Esophageal Cancer: An Audit from a Regional Cancer Centre.Chemoradiotherapy for esophageal cancer.A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.Radiation field size and dose determine oncologic outcome in esophageal cancer.Accomplishments in 2008 in the management of esophageal cancerSEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.Salvage esophagectomy.High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis.The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?Outcomes of definitive chemoradiation in patients with esophageal cancer.Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas.Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer.Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach?Phase II study of concurrent chemoradiotherapy with a modified target volumes delineation method for inoperable oesophagealcancer patients.Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation.Radiation dose to the lymph drainage area in esophageal cancer with involved-field irradiation.Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus.The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma.Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma.Radiotherapy for esophageal cancer using simultaneous integrated boost techniques: dosimetric comparison of helical TomoTherapy, Volumetric-modulated Arc Therapy (RapidArc) and dynamic intensity-modulated radiotherapy.Application of serial section method to determine the radiotherapy target volume for esophageal squamous carcinoma.Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence?A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma.A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma.A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers.
P2860
Q30411811-B221918D-C299-4408-A357-2C12DF82A384Q33439909-2A2970C4-AD41-458B-A3C3-C21A57509AC6Q33823039-C7ACE6DF-85BD-4A3D-827F-948273126EF9Q33841542-96A36EAA-6168-46A3-947C-EACF335F56FBQ33913820-519FB714-A478-467E-9D3A-79E4C4165A9AQ34474357-0149F2CC-E505-4D6A-A274-E54E26943D3FQ35129698-2A2C973C-9BC0-4C17-A6CF-C4FA43DE0D8EQ36200617-A588DBD9-CD48-4820-B645-1198FBE731F3Q36212799-CA759C95-1FA6-48B6-91B8-984D95AE7826Q36328330-2BEC565B-6065-43E3-B30C-A9F4E209A2A9Q36755467-3D1F4228-D0C2-4917-89EA-4A9FB80263E5Q36810301-24858330-17E0-4E94-B232-4AD1CEFE95DEQ37151826-B4FB1D44-D505-45E7-8464-D624294A81E4Q37198622-960B6EFE-6330-44BB-BA04-BBBA8FE0E5C2Q37229239-293004B1-CD4B-45CD-95E3-2A84CD97B9DDQ37340815-A2C8D847-78D3-4430-B044-69EBC60C6326Q37468864-8B06327C-2B11-4E48-B795-DB983986156AQ37475210-8292C0BE-072F-485C-88BD-BDD72E3DB710Q37624523-46B5F7AC-DB94-43B0-85A8-FBF6F5CE0480Q38216029-677D25D2-9C54-4931-9501-C98CCD6450C5Q38559388-8B06C27B-8E3C-4A1B-9925-1F11DA30CB07Q38854234-3FF5424F-141E-4D88-AEDF-E0FEDB2783FDQ39015045-D90B3762-E3A8-4B07-8C45-BEDAE220554AQ39157407-CC4D3081-5D1F-40A8-9E16-5F9114BA5A83Q39204464-241FE8E2-B157-4F3E-9162-F897D33A4922Q39933959-D808FBA7-1378-45E2-8466-7B9FCDFDFF9FQ39995278-0752BBA2-D5FE-41ED-A70D-001A65FD7F07Q40106242-D84512D4-5A97-4D51-8CE1-A7BC2B30D669Q41955525-DFD6D291-5370-4510-8B10-C183C02F9128Q43068197-B75A5624-DC8D-4109-91B4-0B53E1535563Q43379701-EA20623C-3357-47DC-8B0B-07FAC67A9A7FQ43593864-C20FD336-E4AD-4CB9-995E-B0C6E2165B5AQ45815728-00E372A3-02DA-4CD0-8404-3023E3D65523Q45899297-3F3E88F7-54C7-4AFF-B4E8-22ECE73F2E21Q46945838-B7F8A0D2-FFE9-46C0-8BDF-B94737264F56Q47102620-7550A424-C5BC-4E3A-BBC5-B8EF2F8A3493Q47149065-C7B288E1-EA99-45E6-8356-50604379DD32Q50045410-7704BE2C-0297-4545-A102-E85033C03DBEQ50321726-87CEAA72-44C2-4A17-A277-C69A24B10D63Q52649745-5470EEE8-4FF6-4CE6-9D54-A9F8AE1C8525
P2860
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II randomized trial of t ...... ma of the esophagus: RTOG 0113
@en
Phase II randomized trial of t ...... a of the esophagus: RTOG 0113.
@nl
type
label
Phase II randomized trial of t ...... ma of the esophagus: RTOG 0113
@en
Phase II randomized trial of t ...... a of the esophagus: RTOG 0113.
@nl
prefLabel
Phase II randomized trial of t ...... ma of the esophagus: RTOG 0113
@en
Phase II randomized trial of t ...... a of the esophagus: RTOG 0113.
@nl
P2093
P2860
P921
P356
P1476
Phase II randomized trial of t ...... ma of the esophagus: RTOG 0113
@en
P2093
Bruce D Minsky
Christopher G Willett
David Hornback
David P Kelsen
Jaffer A Ajani
Jeffrey Bradley
Kathryn Winter
Mitchel Fromm
Zhongxing Liao
P2860
P304
P356
10.1200/JCO.2008.16.6918
P407
P577
2008-06-23T00:00:00Z